Three-pore model predictions of 24-hour automated peritoneal dialysis therapy using bimodal solutions

Peritoneal Dialysis International

Volumn 31, Issue 5, 2011, Pages 537-544

  Akonur, Alp ^a   Ken Leypoldt, J ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Bimodal; Icodextrin; Sodium removal; Ultrafiltration efficiency

Indexed keywords

EXTRANEAL; GLUCOSE; ICODEXTRIN; PERITONEAL DIALYSIS FLUID; SODIUM;

ARTICLE; CARBOHYDRATE ABSORPTION; COMPUTER PREDICTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; GLUCOSE ABSORPTION; HUMAN; KIDNEY FUNCTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROCESS MODEL; SODIUM EXCRETION; TIME SERIES ANALYSIS; ULTRAFILTRATION;

COMPUTER SIMULATION; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM; ULTRAFILTRATION;

EID: 84856206624     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00169     Document Type: Article

References (26)

1. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12:1046-51.
2. Davies SJ. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy. Kidney Int Suppl 2006; (103):S76-83.
3. Holmes CJ, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006; (103):S104-9.
4. Mistry CD. Glucose polymer as an osmotic agent in continuous peritoneal dialysis [MD thesis]. London, UK: University of London; 1988.
5. Peers E. Icodextrin plus glucose combinations for use in CAPD. Perit Dial Int 1997; 17(Suppl 2):S68-9.
6. Jenkins SB, Wilkie ME. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin) demonstrating improved ultrafiltration compared to either component studied alone. Perit Dial Int 2003; 23:475-80.
7. Dallas F, Jenkins SB, Wilkie ME. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study. Perit Dial Int 2004; 24:542-6.
8. Freida P, Galach M, Divino Filho JC, Werynski A, Lindholm B. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long dwell. Perit Dial Int 2007; 27:267-76.
9. Freida P, Issad B, Dratwa M, Lobbedez T, Wu L, Leypoldt JK, et al. A combined crystalloid and colloid PD solution as a glucose-sparing strategy for volume control for high-transport APD patients: a prospective multicenter study. Perit Dial Int 2009; 29:433-42.
10. Galach M, Werynski A, Waniewski J, Freida P, Lindholm B. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents. Perit Dial Int 2009; 29:72-80.
11. Rippe G, Levin L. Computer simulation of ultrafiltration profiles for an icodextrin-based fluid in CAPD. Kidney Int 2000; 57:2546-56.
12. Akonur A, Holmes CJ, Leypoldt JK. Ultrafiltration efficiency during automated peritoneal dialysis using glucose-based solutions. Adv Perit Dial 2008; 24:69-74.
13. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
14. Vonesh EF, Story KO, O'Neill WT. A multinational clinical validation study of PD Adequest 2.0. PD Adequest International Study Group. Perit Dial Int 1999; 19:556-71.
15. Vonesh EF, Rippe B. Net fluid absorption under membrane transport models of peritoneal dialysis. Blood Purif 1992; 10:209-26.
16. Stelin G, Rippe B. A phenomenological interpretation of the variation in dialysate volume with dwell time in CAPD. Kidney Int 1990; 38:465-72.
17. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40:315-25.
18. Vonesh EF, Story KO, Douma CE, Krediet RT. Modeling of icodextrin in PD Adequest 2.0. Perit Dial Int 2006; 26:475-81.
19. Lin A, Qian J, Li X, Yu X, Liu W, Sun Y, et al. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol 2009; 4:1799-804.
20. Rodriguez-Carmona A, Fontán MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 2002; 22:705-13.
21. Heimbürger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41:1320-32.
22. Blake PG. Novel approaches to prescribing icodextrin. Perit Dial Int 2009; 29:412-14.
23. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20(Suppl 4):S22-42.
24. Mujais S, Vonesh E. Profiling of peritoneal ultrafiltration. Kidney Int Suppl 2002; (81):S17-22.
25. Waniewski J, Debowska M, Lindholm B. How accurate is the description of transport kinetics in peritoneal dialysis according to different versions of the three-pore model? Perit Dial Int 2008; 28:53-60.
26. Venturoli D, Jeloka TK, Ersoy FF, Rippe B, Oreopoulos DG. The variability in ultrafiltration achieved with icodextrin, possibly explained. Perit Dial Int 2009; 29:415-21.